UFPT — UFP Technologies, Inc. stock price, charts and financials

QT71UFP Technologies, Inc.

UFP Technologies, Inc. (NASDAQ: UFPT) is a Healthcare company in the Medical - Devices industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
334.84
+67.31+25.16%
UFPTQT71UFP Technologies, Inc.·NASDAQ
334.84+25.16%
Earnings
Up 25.2% — Company announced record Q2 results with EPS beat of 6%, driving strong positive sentiment.
High confidence
TA
Loading chart...
Screen all →
Snapshot
Index-P/E38.05EPS (ttm)8.80Insider Own11.08%Shs Outstand7.74MPerf Week29.75%
Market Cap2.59BForward P/E31.40EPS next Y10.66Insider Trans-0.47%Shs Float7.43MPerf Month23.07%
Enterprise Value2.72BPEG3.05EPS next Q-Inst Own-Short Float16.73%Perf Quarter73.90%
Income68.00MP/S4.25EPS this Y7.98%Inst Trans-Short Ratio5.63Perf Half Y30.86%
Sales609.00MP/B5.90EPS next Y12.21%ROA10.17%Short Interest1.24MPerf YTD50.81%
Book/sh56.74P/C129.53EPS next 5Y12.47%ROE16.61%52W High338.70 -1.14%Perf Year47.79%
Cash/sh2.58P/FCF28.39EPS past 3/5Y17.18% 37.72%ROIC12.31%52W Low173.86 92.59%Perf 3Y75.06%
Dividend Est.-EV/EBITDA23.46Sales past 3/5Y19.43% 27.49%Gross Margin28.35%Volatility5.34% 4.59%Perf 5Y457.60%
Dividend TTM-EV/Sales4.47EPS Y/Y TTM16.09%Oper. Margin15.20%ATR (14)14.58Perf 10Y1337.70%
Dividend Ex-Date-Quick Ratio1.69Sales Y/Y TTM20.83%Profit Margin11.27%RSI (14)80.65Recom2.00
Dividend Gr. 3/5Y-Current Ratio2.91EPS Q/Q-8.10%SMA2033.27%Beta1.10Target Price298.00
Payout0.00%Debt/Eq0.35Sales Q/Q4.05%SMA5037.40%Rel Volume2.88Prev Close267.53
Employees4,846LT Debt/Eq0.32EarningsNov 02SMA20048.01%Avg Volume221.13KPrice334.84
IPO DateDec 17, 1993Option/ShortYes / YesEPS/Sales Surpr.6.20% -0.37%Net Debt/EBITDA1.17Volume637,522Change25.16%
Analyst Ratings
DateActionAnalystRatingTarget
May-07-25ReiteratedLake StreetBuy$392$252
Jul-17-24ReiteratedLake StreetBuy$270$392
Jul-02-24ReiteratedLoop Capital Markets$300$344
Jun-28-24ReiteratedLoop Capital Markets$231$300
May-02-24ReiteratedLake StreetBuy$231$270
Apr-12-24ReiteratedLoop Capital Markets$231
Latest News
Aug-04-26
Aug-03-26
Jul-30-26
Jul-30-2604:04PM
Jul-29-26
Jul-23-26
Jul-22-26
Jul-09-26
Jul-01-26
Company

UFP Technologies, Inc. specializes in the engineering and custom fabrication of components, subassemblies, finished products, and packaging, primarily utilizing advanced foams, films, and plastics. A significant portion of its business is dedicated to the medical sector, where its single-use and single-patient devices and parts are integral to a broad spectrum of applications, including general medical devices, disposable wound care, infection control, minimally invasive surgical tools, wearable technologies, orthopedic soft goods, and protective packaging for orthopedic implants. Beyond healthcare, the company extends its expertise to the automotive, aerospace and defense, consumer, electronics, and industrial markets. Here, its engineered products and components are incorporated into diverse items such as military uniform and gear, automotive interior trim, athletic padding, sustainable protective packaging, air filtration systems, abrasive nail files, and custom protective cases and inserts. UFP Technologies markets and distributes its offerings across the United States, predominantly through a direct sales force supported by independent manufacturer representatives. The company, established in 1963, is headquartered in Newburyport, Massachusetts.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue609603504400354206179198190
Cost of Goods Sold Incl. D&A437432358288264155135144142
Gross Profit1731701471129051455448
Selling, General and Administrative Excl. Other807762514629272928
Research and Development0000000011
Other Operating Expense-1144-11110-11
Operating Income929281585521172520
Interest Expense9108430011
Unusual Expense
Non-Operating Income (Expense)
000000000
Net Income Before Taxes858373545321162418
Income Taxes1514149115344
Consolidated Net Income686859454216132014
Net Income From Continuing Operations686859454216132014
Net Income686859454216132014
EPS (Recurring)8.908.877.695.895.522.111.792.661.95
EPS (Basic, Before Extraordinaries)8.908.877.695.895.522.111.792.661.95
EPS (Diluted)8.808.777.585.835.452.091.772.631.93
EBITDA11611696696730253228
Other After Tax Adjustments
Stock Option Compensation Expense
Price To Earnings Ratio38.0525.3232.2629.5121.6333.6226.3318.8615.56
Price To Sales Ratio4.402.953.883.442.662.731.821.751.11
Gross Margin28.4128.1929.1728.0025.4224.7625.1427.2725.26
Operating Margin15.1115.2616.0714.5015.5410.199.5012.6310.53
Net Margin11.1711.2811.7111.2511.867.777.2610.107.37
Shares Outstanding888888777
Market Capitalization2,6791,7761,9561,376943562326347210
Operating Lease Expense
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$357.27$308.67$260.06$211.45$162.85 Close Price0.00K158.74K317.49K476.23K634.98KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
FELDMANN CYNTHIA LDirectorJun 12 '26Option Exercise43.951,20052,7406,676Jun 15
FELDMANN CYNTHIA LDirectorJun 12 '26Sale239.291,200287,1495,476Jun 15
CROTEAU DANIEL CDirectorMay 12 '26Sale221.712,864634,977855May 13
CROTEAU DANIEL CDirectorMay 08 '26Option Exercise22.022,86463,0653,719May 12
OBERDORF THOMASDirectorMar 11 '26Option Exercise22.022,86463,06512,417Mar 12
Holt JasonVice PresidentDec 10 '25Sale213.5810021,3587,678Dec 12
Litterio Christopher P.Senior Vice PresidentNov 06 '25Sale227.201,829415,55010,756Nov 12
CROTEAU DANIEL CDirectorSep 05 '25Sale206.022,873591,883855Sep 08
CROTEAU DANIEL CDirectorAug 07 '25Option Exercise22.361,31829,4703,728Aug 14
OBERDORF THOMASDirectorMay 12 '25Option Exercise19.972,92158,3328,928May 14
Litterio Christopher P.Senior Vice PresidentMay 08 '25Sale220.121,473324,24112,585May 12
FELDMANN CYNTHIA LDirectorFeb 28 '25Sale230.722,756635,8754,049Mar 05
FELDMANN CYNTHIA LDirectorFeb 28 '25Option Exercise38.612,756106,4096,805Mar 05
CROTEAU DANIEL CDirectorFeb 27 '25Sale228.416,8461,563,7241,785Mar 03
LATAILLE RONALD JChief Financial OfficerFeb 27 '25Buy229.0940091,63615,031Feb 27
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.